Current Research Studies
An Observational Study of VYKATTM XR (Diazoxide Choline Extended-Release Tablets) in Patients with Prader-Willi Syndrome (PWS)
Soleno-C623
What is the goal of the study?
This is a prospective observational drug study developed to generate more evidence of the safety profile, clinical characteristics, and outcomes of patients with PWS treated with VYKAT XR in a real-world setting. The study will take place in the US. It is anticipated that approximately 200 patients will be enrolled and followed for up to 2 years in this observational study.
Who can participate in the study?
Please contact the study team listed below to learn more.